Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Invest 131 (12), e146353
Medicare is currently prohibited by law from covering Wegovy and other medications when used specifically for obesity
Men and women in generally good health and possess reasonable expectations for weight loss are typically candidates for Semaglutide peptide therapy
Liraglutide Liraglutide is another FDA-approved GLP-1 receptor agonist, available only as a daily injection and under the brand names Victoza and Saxenda
US$ 20.72
US$ 20.26
US$ 24.55
